Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill

Hims & Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its forthcoming obesity pill on the telehealth site. Hims does not yet have an agreement with Novo and there’s “a possibility that no definitive agreement may ever be executed with Novo Nordisk,” the company said in a statement released on Monday. Novo confirmed it was in “preliminary” talks with Hims, the company told Bloomberg News. Most Read from Bloomberg A partnership between the two compani ...